Transcatheter Aortic Heart Valve Devices Market

Published April 2022 | 10 Pages | 5 Exhibits | Forecasts Through 2026

snapshot
snapshot

Order individually or subscribe and get a complete intel platform.

Overview

This report from Life Science Intelligence provides an analysis of the global market for transcatheter devices for the repair and/or replacement of the aortic valve. This thriving medtech market is anticipated to see strong growth, which is largely being driven by the improved access to larger subsets of patients via clinical studies that show the benefit of these technologies in lower risk patients. Epidemiological factors, chiefly the increasing prevalence of heart valve disease, is also increasing the outlook of the TAVI/TAVR devices market.

This market snapshot is intended to provide a high-level overview of the global TAVI/TAVR market, with key insights into:

  • Unit volumes from 2020 to 2026
  • Market forecasts from 2020 to 2026
  • Competitive landscape analysis of major competitors
  • Insights into key market events for strategics and startups

Companies Covered

Abbott

Boston Scientific

Edwards Lifesciences

Foldax

JenaValve Technologies

LivaNova

Medtronic

Pi-Cardia

Venus Medtech

Accelerate your business

We’re here to help you make smarter decisions and form stronger partnerships through curated events, independent market intelligence products and services, and digital-forward media.